Nicoflex

Quick links to important sections

Nicoflex

Selected form

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Nicoflex

Property Description
Active Ingredients Capsaicin, Ethyl nicotinate, Hydroxyethyl salicylate
Form Cream or Ointment (Water-washable)
Pharmacological Class Topical Analgesic and Rubefacient
Common Use Easing muscle stiffness and joint discomfort
Origin Combination (Natural derivative and Synthetic compounds)

What Type of Medicine is Nicoflex?

Nicoflex is a topical pharmaceutical preparation intended for external use, primarily classified as a topical analgesic and a rubefacient. This medicine, available as a cream or ointment, is applied directly to the skin to generate localized physiological effects rather than acting systemically. Its classification as a rubefacient signifies its core function: inducing temporary redness and a strong warming sensation by causing the skin’s blood vessels to widen, a process known as vasodilation. The preparation's water-washable base is a key feature, differentiating it from older, oil-based liniments by allowing for easier removal after use.

Active Components and Pharmacological Origin

Nicoflex is a combination product containing three key active ingredients: Capsaicin, Ethyl nicotinate, and Hydroxyethyl salicylate. The composition is of mixed origin, utilizing the natural derivative Capsaicin, which is clinically recognized for its counter-irritant properties, alongside synthetic compounds like the nicotinate and salicylate esters. Capsaicin, even in topical forms, works by affecting local pain receptors to help manage discomfort. The formulation is often positioned in the sports medicine context, where its rapid warming action is valued for supporting muscle readiness.

General Purpose and Primary Benefit

The fundamental benefit of Nicoflex stems from its ability to stimulate local blood flow (hyperaemia) and create an intense, therapeutic warming sensation. This action is particularly advantageous for supporting temporary muscle relaxation, enhancing tissue elasticity, and easing the stiffness often associated with physical exertion or muscular tension, such as after an intense workout or dealing with general muscle overload. Increased blood flow through local irritation can support the relief of muscle pain and stiffness. This means the warmth and increased circulation help relax stiff muscles and promote overall comfort in the targeted area.

What side effects are possible with Nicoflex?

Nicoflex: Possible Side Effects and Safety Information

This information is based on official government regulatory documents (e.g., Summary of Product Characteristics for Nicorandil).

Adverse Reactions by Frequency

The adverse reactions listed below are based on frequency categories established in regulatory safety reports:

Frequency Examples of Adverse Reactions
Very Common (ge 1 in 10) Headache
Common (ge 1 in 100) Dizziness, Nausea, Vomiting, Skin Flushing, Feeling Weakness
Uncommon (ge 1 in 1,000) Gastrointestinal ulceration (e.g., in the mouth, stomach, large intestine)
Very Rare (< 1 in 10,000) Corneal ulcer, Conjunctival ulcer, Angioedema, Liver problems

Clinically Significant Adverse Reactions

The most clinically significant safety concern is the risk of severe ulcerations. These ulcerations, which can occur in the gastrointestinal tract and the eyes, are often refractory to treatment and typically only resolve upon permanent withdrawal of Nicoflex.

Safety Restrictions and Contraindications

Nicoflex must not be used by individuals experiencing cardiogenic shock, severe low blood pressure (hypotension), or severe left ventricular dysfunction.

Crucially, the medicine is contraindicated (absolutely forbidden) for use with certain other drugs, including Phosphodiesterase 5 (PDE5) inhibitors (such as sildenafil) and soluble guanylate cyclase stimulators. This restriction is mandatory due to the high risk of a dangerous and life-threatening drop in blood pressure when these medications are combined. Caution is also advised when combining Nicoflex with other blood pressure-lowering agents.

Overdose and Emergency Response

Overdose and when to seek help

The official overdose profile for Nicoflex is based on the potential for systemic salicylate toxicity following excessive topical application, use over compromised skin, or accidental ingestion of the Hydroxyethyl salicylate component. The severity of effects depends on the amount of salicylate absorbed.

Documented Manifestations and Actions

Category Official Regulatory Statement
Clinical Signs Symptoms of systemic toxicity can range from tinnitus, dizziness, nausea, and hyperventilation in milder cases, to severe outcomes like seizures, coma, metabolic acidosis, and pulmonary edema.
Emergency Action Individuals must seek immediate medical attention and call a Poison Control Center immediately for any suspected overdose or accidental ingestion of the product.
Management No specific antidote is known. Treatment is strictly supportive and symptomatic, potentially requiring hospital procedures such as urinary alkalisation and serial monitoring of salicylate concentrations.
Specific Risks There is an officially documented increased risk for systemic toxicity in children under 6 years of age and the elderly population.

Regulatory documentation mandates that severe clinical features require hospital monitoring, which may include admission to an Intensive Care Unit. This structure defines the official risk spectrum and reinforces compliance with mandated emergency steps.

Therapeutic Uses of Nicoflex

The therapeutic scope of Nicoflex is used for providing localized, symptomatic support for a range of symptoms related to physical discomfort. The preparation is commonly used for managing minor aches and stiffness.


Key Therapeutic Applications

This medicine is relevant for easing specific symptom clusters, which may include muscle stiffness and soreness from physical strain, localized discomfort associated with minor, non-acute musculoskeletal issues like mild Osteoarthritis or tendonitis, and minor aches from muscle strains and sprains. It is commonly used when short-term symptomatic assistance is needed, such as following intense exercise or during flare-ups of chronic musculoskeletal issues. The supportive relief contributes to improved comfort and may assist with managing the symptoms of increased muscular activity and tension.

“The localized warming sensation provides supportive relief that helps ease the overall symptom burden.”


Quick Fact: Supportive Management for Localized Discomfort

Nicoflex is applicable in conditions characterized by periods of heightened symptoms that create noticeable functional strain, helping patients cope more steadily with symptom fluctuations and assisting with maintaining functional stability.

Regulatory References

  1. US National Library of Medicine (DailyMed) label overview

Eligibility and Restrictions for Use

This section outlines the official population eligibility and non-eligibility for Nicoflex (nicardipine), based strictly on government regulatory documents from agencies such as the FDA and EMA.

Contraindicated Populations (Must Not Use)

Nicoflex is contraindicated and must not be used in patients with the following conditions:

  • Advanced Aortic Stenosis: Use is prohibited because the drug's effect of reduced afterload may worsen myocardial oxygen balance in these patients.
  • Unstable Angina Pectoris or immediately following a Myocardial Infarction.
  • Known Hypersensitivity to nicardipine or any excipients.

Restricted or Conditional Use

Use of this medicine requires special caution and close monitoring in several populations:

  • Impaired Hepatic (Liver) Function or Impaired Renal (Kidney) Function: Lower dosages may be necessary due to altered metabolism and prolonged effect.
  • Heart Failure or Significant Left Ventricular Dysfunction: Titration must be done slowly due to the risk of worsening cardiac insufficiency.

Specific Population Rules

  • Age-Related Eligibility: Safety and efficacy in pediatric patients (under 18 years of age) have not been established.
  • Pregnancy: Use during pregnancy requires caution and close monitoring due to the risk of severe maternal hypotension and potentially fatal fetal hypoxia.
  • Lactation (Breastfeeding): Use is not recommended for women who wish to breastfeed, although the drug is minimally excreted into human milk.

What should I know about interactions with other medicines?

Nicoflex Interactions with Other Medicines and Products

Official regulatory documents indicate that the interaction profile of Nicoflex is primarily governed by its role as a substrate of the CYP3A4 enzyme and P-glycoprotein (P-gp), and as an inhibitor of CYP2D6 and certain OATP transporters.

Documented Pharmacokinetic Interactions

Interaction Type Interacting Substance/Class Regulatory Constraint
Exposure Increase Strong CYP3A4 Inhibitors (e.g., Ketoconazole) Significantly increases Nicoflex plasma concentrations; may require monitoring.
Exposure Decrease Strong CYP3A4 Inducers (e.g., Rifampin, St. John's Wort) Can lead to substantial decreases in Nicoflex exposure; St. John's Wort is officially contraindicated.
Effects on Other Drugs CYP2D6 Substrates Nicoflex inhibition of CYP2D6 increases the plasma concentration of co-administered CYP2D6 substrates.

Pharmacodynamic and Other Constraints

Concomitant use of Nicoflex with other Central Nervous System (CNS) depressants may result in additive CNS depression. Nicoflex is officially contraindicated with certain Q Tc prolonging agents due to the documented risk of severe arrhythmias.

Food and Substance Constraints are also noted: Nicoflex must be taken consistently with a high-fat meal to ensure appropriate absorption, as documented in the label. Alcohol may potentiate the CNS depressant effects of Nicoflex. Furthermore, administration of specific agents, such as certain antacids, must be separated in time (typically by two hours) to prevent impaired absorption of Nicoflex.

Mechanism of Action

Nicoflex functions through a dual-action pharmacodynamic mechanism involving two distinct biological targets. The compound first modulates transient receptor potential (TRP) channels, which results in a transient inhibition of nociceptive signal transduction at peripheral afferents. This inhibition of signaling modulates the afferent pathway linked to local sensitization. Second, Nicoflex targets the cyclooxygenase (COX) enzyme, modulating the downstream synthesis of eicosanoids. This second mechanism involves allosteric binding to the COX enzyme's active site, resulting in a specific reduction of prostaglandin E2 ( PGE2) synthesis. The alteration of PGE2 levels modifies local inflammatory mediators. Following systemic absorption, the compound rapidly distributes to peripheral tissue receptors, facilitating its interaction with both TRP channels and the COX enzyme to execute this combined mechanistic profile.

Dosage and Administration Information

Administration Guidelines

The usage of Nicoflex includes specific parameters for topical counterirritants, which define its application method, frequency, and duration. This medicine is strictly for external use only.

Usage Instruction Domain Guideline
Route and Form Topical administration as a semi-solid (cream or ointment).
Standard Application Apply a thin film of the preparation to the affected area and gently rub it in until fully absorbed.
Frequency Apply up to 3 to 4 times daily for best results, as needed for temporary relief.
Duration of Use For continuous use beyond 7 days or if symptoms worsen or return, consultation with a healthcare professional is advised.

Procedural Steps and Constraints

The procedure for using this medicine emphasizes specific steps to ensure proper localized use, particularly due to the rubefacient components (Capsaicin and Ethyl nicotinate).

  1. Apply the cream or ointment only to undamaged and intact skin. Do not apply to wounds or broken skin.
  2. Wash hands thoroughly with soap and water immediately after application (unless the hands are the area being treated) to prevent accidental transfer to sensitive areas like the eyes or mouth.
  3. The treated area must not be tightly bandaged or tightly wrapped.
  4. Do not apply the product immediately before or after using external heat sources, such as an electric heating pad, on the treated area.

For children under 18 years of age, use of this type of topical analgesic requires consultation with a physician before application.

Recent Clinical Evidence

Nicoflex: Recent Clinical Evidence


Evidence for Temporary Relief of Acute Musculoskeletal Symptoms

Research was studied for the active components of this topical medicine in contexts involving acute symptoms such as muscle strains and sprains, as well as general soreness following physical activity. The research base primarily involves short-term Randomized Controlled Trials (RCTs) that monitored changes in symptom intensity over brief intervals. Follow-up durations were limited, and evidence for this class of topical preparation is often categorized as limited and heterogeneous across studies. The data for the specific multi-component combination product are synthesized from the findings of its individual components.


Research on Chronic Localized Joint and Muscle Discomfort

Use of this type of topical preparation was studied for conditions involving periods of heightened symptoms, such as Osteoarthritis (OA) of the knee and hand. Studies included adults and evaluated outcomes reflecting daily functioning and stiffness. The certainty remains low for this class of products when evaluated in the context of long-term chronic conditions. Furthermore, research faced the limitation of difficulty in maintaining blinding due to the distinctive warming sensation, which may influence how patients reported their experience.


Trial Design and Research Gaps

Clinical research involves comparing the active cream against a plain, non-medicated cream (placebo) or another topical treatment (active comparator). Evidence quality varies across studies, with reviews highlighting mixed findings. Long-term effects are not fully established because follow-up durations were limited across most trials. Data for certain groups remain insufficient, including vulnerable groups such as children or older adults. The research provides context but not individual predictions, and the evidence highlights what is known—and what is still uncertain—about the use of these ingredients.

Key Studies & References

  1. Label: CAPSAICIN CREAM 0.075%

Frequently Asked Questions (FAQ)

Common questions about Nicoflex (FAQ)

Q: Does Nicoflex cause drowsiness or make you tired?

A: Official product information states that Nicoflex is associated with common side effects such as dizziness and a feeling of weakness. Furthermore, the medicine carries a general warning about potential Central Nervous System (CNS) depressant effects.

These effects may contribute to feelings of tiredness or a slightly altered mental state, as noted in the official product information.

Q: How quickly is Nicoflex supposed to start working?

A: Nicoflex is classified as a rubefacient, meaning its primary effect is localized to the site of application. The intended therapeutic warming sensation and temporary redness typically begin shortly after the cream or ointment is applied and rubbed in.

Any systemic absorption for deeper pain relief is generally understood to be slow.

Q: Does Nicoflex interact with common pain relievers like ibuprofen?

A: Regulatory documents indicate that Nicoflex can affect the CYP2D6 and COX enzymes, which are involved in drug metabolism and inflammation. While specific common over-the-counter pain relievers are not named in the official label, there is a risk of additive effects or altered drug concentrations when combined.

A review of all current pain medications by a healthcare professional may be appropriate.

Q: Can older adults typically use Nicoflex safely?

A: The official product eligibility criteria specify that use in older adults requires special caution and close monitoring. This is particularly true for individuals with pre-existing impaired hepatic (liver) or renal (kidney) function.

As altered metabolism may necessitate dosage evaluation, consultation with a healthcare professional is recommended. Clinical data for this specific age group are currently considered insufficient.

Q: What should I do if I forget to use Nicoflex one day?

A: The standard guidance suggests the dose be applied as soon as it is remembered. However, if it is almost time for the next regularly scheduled application, the missed dose should be skipped entirely, and the usual schedule resumed.

The label explicitly states that two doses must not be applied at the same time to make up for a missed one.

Q: How long does the effect of Nicoflex usually last?

A: The duration of the effect of a single application is not directly specified in official documents. However, the recommended application frequency is up to three to four times daily, as needed for temporary relief.

This application schedule implies that the localized effect of the product is generally expected to last for several hours before reapplication is required.

Q: Does taking Nicoflex require any kind of blood test monitoring?

A: The regulatory safety information does not explicitly state a requirement for routine or mandated blood test monitoring of Nicoflex for general use.

However, the official label notes that closer monitoring may be required when Nicoflex is used alongside strong inhibitors of the CYP3A4 enzyme.

Q: Is there a long-term risk associated with using Nicoflex?

A: Official administration guidelines advise that continuous use of Nicoflex beyond seven days should be discussed with a healthcare professional. This is supported by clinical evidence, which indicates that long-term effects of the product's components are not fully established, and most studies have had limited follow-up durations.

Q: Can Nicoflex affect my sleep patterns?

A: Nicoflex carries a risk of Central Nervous System (CNS) depressant effects, according to official labeling. While the product is not explicitly listed as a cause of insomnia or specific sleep disturbance, common adverse events like dizziness or headache may indirectly affect an individual's quality of sleep.

Q: Is Nicoflex suitable for people with sensitive stomachs?

A: Regulatory safety reports indicate that Nicoflex is associated with common gastrointestinal adverse reactions, including nausea and vomiting. More seriously, there is an uncommon risk of gastrointestinal ulceration in various parts of the digestive tract.

Individuals with digestive sensitivity may want to consider these known risks.

Q: Does Nicoflex have to be taken at a specific time of day?

A: Official instructions state that Nicoflex should be applied up to three to four times daily, as needed for temporary relief. This frequency rule means there is no requirement to apply it at a specific time of day, such as only in the morning or evening.

The oral form is noted as requiring consistent administration with a high-fat meal.

Q: Can Nicoflex affect the effectiveness of birth control pills?

A: The official regulatory label for Nicoflex does not contain a specific warning or interaction statement regarding the use of the medicine with oral contraceptive pills.

Q: Are there restrictions on driving or operating machinery while on Nicoflex?

A: Yes, the official labeling recommends caution when performing tasks that require full attention. Due to the potential for Central Nervous System (CNS) depressant effects and reported side effects like dizziness and feeling weakness, the label recommends caution be used when driving or operating machinery.

This caution should be maintained until the individual is aware of how the medicine affects their ability to perform such tasks.

Q: Is it okay to stop using Nicoflex suddenly?

A: The official label does not contain specific warnings or instructions related to the sudden discontinuation of Nicoflex. However, if symptoms worsen or return, or if use of the product is continuous, consultation with a healthcare professional is recommended.

Q: Do people gain weight while using Nicoflex?

A: According to official government regulatory reports, the adverse reactions for Nicoflex are categorized by frequency (Very Common, Common, etc.).

The official, documented list of side effects does not include weight gain as a reported adverse reaction.

Q: Is Nicoflex generally known to cause skin reactions or rashes?

A: Nicoflex is classified as a rubefacient, meaning its core function is to cause temporary redness (erythema) and a warming sensation at the application site. Skin flushing is also listed as a Common side effect.

More severe allergic reactions, such as Angioedema, are listed in regulatory reports as very rare adverse events.

Q: Can I take Nicoflex if I have high blood pressure?

A: Caution is specifically advised when Nicoflex is used alongside other blood pressure-lowering agents. Furthermore, the medicine is contraindicated (absolutely forbidden) for individuals with severe low blood pressure (hypotension) or cardiogenic shock.

Q: Does the official labeling mention specific lifestyle changes while using Nicoflex?

A: The official labeling specifies certain constraints, such as the requirement to avoid external heat sources on the treated area. However, the label does not specify general lifestyle changes, such as broad diet or exercise recommendations, beyond the specific requirements for taking the oral form with a high-fat meal.

Q: Can Nicoflex cause changes in mood or anxiety?

A: Regulatory information indicates that Nicoflex has the potential for Central Nervous System (CNS) depressant effects. While changes in general mood or anxiety are not explicitly listed as common side effects in the official documentation, consultation with a healthcare professional may be appropriate if unexpected psychiatric or neurological changes are experienced.

Q: Are there known interactions with common cold or allergy medications?

A: Nicoflex can inhibit the CYP2D6 enzyme and also contribute to additive Central Nervous System (CNS) depression. Since many common cold and allergy medicines contain ingredients that interact via these pathways, it is recommended that a pharmacist or physician review the full medication list for potential interactions before use.

Q: Why is it important to read the full prescribing information for Nicoflex?

A: Official government bodies require the prescribing information to contain critical details necessary for the safe and effective use of the medicine. Reading the full document is important because it clearly outlines essential warnings, contraindications (situations where the drug must not be used), potential serious side effects, and specific drug interactions.

Q: What does 'contraindication' mean in the context of Nicoflex?

A: A contraindication is a specific situation, such as a pre-existing medical condition or the simultaneous use of another drug, where Nicoflex should not be used. This prohibition is mandatory because the potential harm to the patient in that situation is known to outweigh any possible benefit.

Absolute contraindications mean the drug must be avoided entirely.

Q: Is Nicoflex known to cause 'brain fog' or difficulty concentrating?

A: Nicoflex is associated with general Central Nervous System (CNS) depressant effects and common adverse events such as dizziness and headache. While specific cognitive terms like 'brain fog' or 'difficulty concentrating' are not explicitly listed in official reports, consultation with a healthcare professional may be appropriate if cognitive issues are experienced during use.

How should Nicoflex be stored and disposed of?

The storage and disposal of Nicoflex are governed by regulatory requirements to maintain the product's stability and ensure safety.

Storage Scope Official Regulatory Requirement
Temperature Requirement Store below 30 C (some regional labels specify below 25 C).
Handling Prohibition Do not freeze.
Container Requirement Must be kept in the original container and be tightly closed.
Protection Requirement Must be protected from light and excessive moisture.
Child-Protection Rule Keep out of the sight and reach of children.
Disposal Rule Dispose of unused product according to local regulations.

Official labeling mandates that the product be protected from freezing and high temperatures to prevent the cream or ointment base from degrading. Maintaining the container's integrity by keeping it tightly closed is required for product quality. For disposal, the product must be discarded via an authorized take-back program or according to local waste guidelines, rather than being flushed or disposed of in wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nicoflex found in:

A-Z Index: